当前位置: X-MOL 学术Life Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside alleviated the acute hepatotoxicity and DNA damage in diethylnitrosamine-contaminated mice.
Life Sciences ( IF 6.1 ) Pub Date : 2020-01-09 , DOI: 10.1016/j.lfs.2020.117274
Weihua Yu 1 , Jiuzhou Zhao 2 , Wenli Li 1 , Yipeng Zheng 2 , Jingpu Zhu 2 , Jiangzheng Liu 1 , Rui Liu 1 , Zhao Wang 1 , Xin Wang 1 , Chunxu Hai 1
Affiliation  

AIMS 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside (TSG) is the key bioactive ingredient extracted from Polygonum multiflorum Thumb. Pharmacological studies suggest that it exerts numerous biological effects, including anti-oxidant, anti-aging, and anti-inflammation. This study aimed at investigating the effect of TSG on diethylnitrosamine (DEN)-induced acute hepatotoxicity and DNA damage. MAIN METHODS Fifty male C57BL/6 mice were randomly divided into 5 groups (n = 10 each): control, DEN, DEN+TSG (low), DEN+TSG (high) and TSG (high) groups. DEN (100 mg/kg) was injected intraperitoneally (i.p.) alone or with TSG (30 or 60 mg/kg, i.p.) for 5 consecutive days. KEY FINDINGS TSG inhibited liver injury and inflammatory cell infiltration in DEN-treated mice. It also attenuated DEN-induced accumulation of reactive oxygen species (ROS), proinflammatory cytokines, and DNA damage. Moreover, TSG promoted the expression of nuclear erythroid 2-related factor 2 (Nrf2) target antioxidant genes by enhancing Nrf2 protein phosphorylation and nuclear translocation. As major phase I detoxification enzymes, cytochrome P450 family 2 subfamily E member 1 (CYP2E1) and cytochrome P450 1 subfamily A member 1 (CYP1A1) are responsible for the metabolic activation of DEN. We found that TSG administration inhibited CYP2E1 and CYP1A1 induction in DEN-treated mice. SIGNIFICANCE These results indicate that TSG can alleviate DEN-induced acute hepatotoxicity by modulating the Nrf2-related antioxidant system and metabolic activation of DEN. Therefore, TSG might be a promising medication for DEN-induced liver injury treatment.

中文翻译:

2,3,5,4'-四羟基sti-2-O-β-d-葡萄糖苷减轻了被二乙基亚硝胺污染的小鼠的急性肝毒性和DNA损伤。

AIMS 2,3,5,4'-四羟基sti-2-O-β-d-葡萄糖苷(TSG)是从何首乌中提取的关键生物活性成分。药理研究表明,它具有多种生物作用,包括抗氧化,抗衰老和抗发炎。这项研究旨在调查TSG对二乙基亚硝胺(DEN)诱导的急性肝毒性和DNA损伤的影响。主要方法将50只雄性C57BL / 6小鼠随机分为5组(每组10只):对照组,DEN,DEN + TSG(低),DEN + TSG(高)和TSG(高)组。连续5天腹膜内(ip)或与TSG(30或60 mg / kg,ip)腹腔注射DEN(100 mg / kg)。主要发现TSG抑制了DEN治疗的小鼠的肝损伤和炎性细胞浸润。它还减弱了DEN引起的活性氧(ROS)积累,促炎细胞因子和DNA损伤。此外,TSG通过增强Nrf2蛋白的磷酸化和核易位,促进了核红细胞2相关因子2(Nrf2)靶抗氧化剂基因的表达。作为主要的I期排毒酶,细胞色素P450家族2亚家族E成员1(CYP2E1)和细胞色素P450 1亚家族A成员1(CYP1A1)负责DEN的代谢活化。我们发现,在DEN治疗的小鼠中,TSG给药抑制了CYP2E1和CYP1A1的诱导。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。TSG通过增强Nrf2蛋白的磷酸化和核易位,促进了核红细胞2相关因子2(Nrf2)靶抗氧化剂基因的表达。作为主要的I期排毒酶,细胞色素P450家族2亚家族E成员1(CYP2E1)和细胞色素P450 1亚家族A成员1(CYP1A1)负责DEN的代谢活化。我们发现,在DEN治疗的小鼠中,TSG给药抑制了CYP2E1和CYP1A1的诱导。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。TSG通过增强Nrf2蛋白的磷酸化和核易位,促进了核红细胞2相关因子2(Nrf2)靶抗氧化剂基因的表达。作为主要的I期排毒酶,细胞色素P450家族2亚家族E成员1(CYP2E1)和细胞色素P450 1亚家族A成员1(CYP1A1)负责DEN的代谢活化。我们发现,在DEN治疗的小鼠中,TSG给药抑制了CYP2E1和CYP1A1的诱导。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。作为主要的I期排毒酶,细胞色素P450家族2亚家族E成员1(CYP2E1)和细胞色素P450 1亚家族A成员1(CYP1A1)负责DEN的代谢活化。我们发现,在DEN治疗的小鼠中,TSG给药抑制了CYP2E1和CYP1A1的诱导。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。作为主要的I期排毒酶,细胞色素P450家族2亚家族E成员1(CYP2E1)和细胞色素P450 1亚家族A成员1(CYP1A1)负责DEN的代谢活化。我们发现,在DEN治疗的小鼠中,TSG给药抑制了CYP2E1和CYP1A1的诱导。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。意义这些结果表明,TSG可以通过调节Nrf2相关的抗氧化剂系统和DEN的代谢活化来减轻DEN引起的急性肝毒性。因此,TSG可能是DEN诱发肝损伤治疗的有前途的药物。
更新日期:2020-01-09
down
wechat
bug